The proportion of eligible persons identified who
are tested for latent tuberculosis (TB), offered treatment, and complete treatment are performance indicators in tuberculosis control. We report a retrospective database
review of the Migrant Screening Clinic, Department of Respiratory and Sleep
Disorders Medicine at Western Health Footscray Hospital during the years
1996-2006.
Of 7,225 migrants aged less than 35 years, tuberculin skin testing
(TST) was performed for 3,589 (49.7%), including 2,641 (65.6%) of 4,024 migrants under 35 years with an abnormal chest
radiograph, and 2,297 (59.0%) of 3,893 migrants born in a high-burden country. Of 3,589 persons
with both chest radiograph and TST results, 1,487 (41.4%) were referred for
follow-up, including 81.3% of those with TST ≥10 mm. Outcome data were
available for 1,047 persons considered for treatment of latent TB, of whom 12.5%
did not attend an initial appointment, 21.6% attended and were not offered treatment, 65.9% attended and were offeredtreatment, and 41.7%
completed treatment for latent TB.
The Victorian program for treatment of latent TB in migrants has testing, treatment offer and treatment completions rates similar to other published
studies. The impact on TB control is limited by the small proportion of migrants referred to this program.
Outcome | n | % |
---|---|---|
Did not attend initial appointment
|
131
|
12.5
|
Attended initial appointment but treatment for latent TB not offered
|
226
|
21.6
|
Treatment of latent TB offered but patient refused
|
144
|
13.8
|
Started but failed to complete treatment for latent TB
|
109
|
10.4
|
Completed 6 months isoniazid
|
224
|
21.4
|
Completed 9 months isoniazid
|
205
|
19.6
|
Completed 2 months rifampicin + pyrazinamide or other treatment of latent TB
|
8
|
0.8
|
Total
|
1,047
|
100.0
|
Full article at: http://goo.gl/x01QfT
- 1Physician, Department of Respiratory and Sleep Disorders Medicine, Western Health, Footscray, Victoria.
- 2Manager, Tuberculosis Control Program, Department of Health, Melbourne, Victoria.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment